Big pharma is going through the greatest ever wave of patent expiries, while small biotechs are finding it hard to …
Vernalis and GlaxoSmithKline have joined forces to work on a cancer treatment in a deal which could be worth more …
GlaxoSmithKline has signed a major deal with Amgen to co-market its new osteoporosis treatment denosumab in Europe, Australia, New Zealand …
GlaxoSmithKline and Oxford-based Chroma Therapeutics are linking up to identify small molecule therapeutics in a bid to combat conditions like …

